Is a complete SPRB research report available?

No complete published report is available for Spruce Biosciences, Inc. (SPRB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Spruce Biosciences, Inc. (SPRB)

NASDAQ: SPRB · USD

$43.4

+1.92 (+4.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SPRB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	119.4M
Net income (ttm)	-37.2M
EPS (ttm)	-$38.6
Shares out	2.8M
Volume	59,129
Beta	3.21
Price target	$151	+248.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -37.2M
EPS (ttm): -$38.6
Market cap: 119.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SPRB indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

USD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001683553
Company name	Spruce Biosciences, Inc.
Country	United States
Country code	US
Cusip	85209E208
Employees	14
Employees Change	6%
Employees Change Percent	75
Enterprise value	$71.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US85209E2081
Last refreshed	2026-07-31
Market cap	$119.4M
Market cap category	Micro-Cap
Price	$43.37
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Symbol	SPRB
Website	https://sprucebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-31.37%
FCF yield	-24.75%
P/B ratio	1.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-10.4M
Net Income	$-37.2M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Profit Per Employee	$-2.7M
ROA	-37.16
Roa5y	-32.76
ROCE	-76.63
ROE	-148.8
Roe5y	-71.97
ROIC	-54.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	387.49%
Cagr3y	-36.41%
Cagr5y	-42.88%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$56.2M
Cash	$54.1M
Current Assets	$55M
Current Liabilities	$11.8M
Debt	$7.1M
Debt Equity	$0.21
Equity	$34.6M
Interest Coverage	-46.71
Liabilities	$21.5M
Long Term Assets	$1.1M
Long Term Liabilities	$9.7M
Net Cash	$47M
Net Cash By Market Cap	$39.6
Net Cash Growth	101.36%
Net Debt Equity	$-1.36
Tangible Book Value	$34.6M
Tangible Book Value Per Share	$25.25
WACC	21.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.67
Net Working Capital	$-9.5M
Quick ratio	4.59
Working Capital	$43.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-72.07%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	386.96%
200-day SMA	73.31
3Y total return	-74.3%
50-day SMA	49.15
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.92%
All Time High	2,670
All Time High Change	-98.38%
All Time High Date	2020-11-27
All Time Low	4.28
All Time Low Change	914.5%
All Time Low Date	2025-04-29
ATR	3
Beta	3.21
Beta1y	-35.41
Beta2y	-10.11
Ch YTD	-50.21
High	43.49
High52	240
High52 Date	2025-10-07
High52ch	-81.93%
Low	41.99
Low52	7
Low52 Date	2025-08-29
Low52ch	519.57%
Ma50ch	-11.76%
Price vs 200-day SMA	-40.84%
RSI	39.74
RSI Monthly	42.46
RSI Weekly	39.69
Sharpe ratio	0.96x
Sortino ratio	17.85
Total Return	-72.07%
Tr YTD	-50.21
Tr1m	-22.39%
Tr1w	-3.6%
Tr3m	-21.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	7
Analyst Price Target Top	$153
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-5.17
Operating Income	$-26.1M
Price target	$151
Price Target Change	$248
Price Target Change Top	$252

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,403,160%
Float Percent	87.32%
Net Borrowing	12,494,000
Shares Insiders	3.6%
Shares Institutions	30.51%
Shares Out	2,752,278
Shares Qo Q	5.72%
Shares Yo Y	72.07%
Short Float	17.3%
Short Ratio	4.57
Short Shares	15.11

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-32.1M
Adjusted OCF	-32,051,000
Average Volume	65,044.25x
Bv Per Share	25.25
CAPEX	$-10,000
Ch1m	-22.39
Ch1w	-3.6
Ch1y	387
Ch3m	-21.88
Ch3y	-74.3
Ch5y	-93.92
Ch6m	-45.69
Change	4.63%
Change From Open	3.29
Close	41.45
Days Gap	1.3
Depreciation Amortization	267,000
Dollar Volume	2,564,424.7
Earnings Date	2026-08-12
Earnings Time	amc
EBIT	$-34M
EBITDA	$-33.7M
EPS	$-38.62
F Score	2
FCF	$-29.3M
FCF EV Yield	-40.97x
FCF Per Share	$-10.66
Financing CF	57,808,000
Fiscal Year End	December
Founded	2,014
Investing CF	-10,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2025-08-07
Last Split Type	Reverse
Ma150	61.06
Ma150ch	-28.97%
Ma20	46.3
Ma20ch	-6.33%
Net CF	28,466,000
Next Earnings Date	2026-08-13
Open	41.99
Optionable	No
Position In Range	92
Post Close	43.37
Postmarket Change Percent	-0.67
Postmarket Price	$43.08
Ppne	595,000
Price Date	2026-07-30
Ptbv Ratio	3.42
Relative Volume	0.91x
Share Based Comp	2,719,000
Tr6m	-45.69%
Us State	California
Volume	59,129

Spruce Biosciences, Inc. (SPRB)

Coverage state: Market snapshot only — no published research

Generate the first SPRB analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SPRB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SPRB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SPRB

Frequently asked questions